These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31314613)

  • 21. Diabetic gastroparesis.
    Kong MF; Horowitz M
    Diabet Med; 2005 Sep; 22 Suppl 4():13-8. PubMed ID: 16109013
    [No Abstract]   [Full Text] [Related]  

  • 22. [Gastroparesis and its treatment options].
    Igaz P; Tulassay Z
    Orv Hetil; 2008 Mar; 149(9):393-8. PubMed ID: 18292033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis.
    Janssen P; Harris MS; Jones M; Masaoka T; Farré R; Törnblom H; Van Oudenhove L; Simrén M; Tack J
    Am J Gastroenterol; 2013 Sep; 108(9):1382-91. PubMed ID: 24005344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic gastroparesis. A critical reappraisal of new treatment strategies.
    Drenth JP; Engels LG
    Drugs; 1992 Oct; 44(4):537-53. PubMed ID: 1281070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From Harmful Treatment to Secondary Gain: Adverse Event Reporting in Dyspepsia and Gastroparesis.
    Bielefeldt K
    Dig Dis Sci; 2017 Nov; 62(11):2999-3013. PubMed ID: 28577245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cisapride on gastric emptying of indigestible solids in patients with gastroparesis diabeticorum. A comparison with metoclopramide and placebo.
    Feldman M; Smith HJ
    Gastroenterology; 1987 Jan; 92(1):171-4. PubMed ID: 3781184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug Insight: from disturbed motility to disordered movement--a review of the clinical benefits and medicolegal risks of metoclopramide.
    Pasricha PJ; Pehlivanov N; Sugumar A; Jankovic J
    Nat Clin Pract Gastroenterol Hepatol; 2006 Mar; 3(3):138-48. PubMed ID: 16511548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol.
    Malagelada JR; Rees WD; Mazzotta LJ; Go VL
    Gastroenterology; 1980 Feb; 78(2):286-93. PubMed ID: 7350052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigational drug therapies for the treatment of gastroparesis.
    Sanger GJ; Pasricha PJ
    Expert Opin Investig Drugs; 2017 Mar; 26(3):331-342. PubMed ID: 28127997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The proportional cumulative area under the curve of paracetamol used as an index of gastric emptying in diabetic patients with symptoms of gastroparesis.
    van Wyk M; Sommers DK; Snyman JR; Moncrieff J
    Clin Exp Pharmacol Physiol; 1995 Sep; 22(9):637-40. PubMed ID: 8542677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of gastroparesis by primperan].
    Robillard J
    Ann Gastroenterol Hepatol (Paris); 1985 May; 21(2 Pt 2):23-6. PubMed ID: 3898990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metoclopramide nasal spray is effective in symptoms of gastroparesis in diabetics compared to conventional oral tablet.
    Parkman HP; Carlson MR; Gonyer D
    Neurogastroenterol Motil; 2014 Apr; 26(4):521-8. PubMed ID: 24372829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastroparesis: New insights into an old disease.
    Usai-Satta P; Bellini M; Morelli O; Geri F; Lai M; Bassotti G
    World J Gastroenterol; 2020 May; 26(19):2333-2348. PubMed ID: 32476797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study.
    Parkman HP; Carlson MR; Gonyer D
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1256-1263.e1. PubMed ID: 25576687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review article: metoclopramide and tardive dyskinesia.
    Rao AS; Camilleri M
    Aliment Pharmacol Ther; 2010 Jan; 31(1):11-9. PubMed ID: 19886950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review article: An analysis of the pharmacological rationale for selecting drugs to inhibit vomiting or increase gastric emptying during treatment of gastroparesis.
    Sanger GJ; Andrews PLR
    Aliment Pharmacol Ther; 2023 May; 57(9):962-978. PubMed ID: 36919196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prokinetics in patients with gastroparesis: a systematic analysis.
    Sturm A; Holtmann G; Goebell H; Gerken G
    Digestion; 1999; 60(5):422-7. PubMed ID: 10473966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metoclopramide therapy in fifty-five patients with delayed gastric emptying.
    Perkel MS; Hersh T; Moore C; Davidson ED
    Am J Gastroenterol; 1980 Sep; 74(3):231-6. PubMed ID: 7468558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current concepts in diabetic gastroparesis.
    Smith DS; Ferris CD
    Drugs; 2003; 63(13):1339-58. PubMed ID: 12825960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prokinetics in gastroparesis.
    Acosta A; Camilleri M
    Gastroenterol Clin North Am; 2015 Mar; 44(1):97-111. PubMed ID: 25667026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.